1 January 2023 in Srce i krvni sudovi
Aortic stenosis (AS) is the most common valvular disease requiring surgical (SAVR) or transcatheter intervention (TAVI) in Europe and North America. The first TAVI was performed in 2002 in order to treat in-operable patients with AS, and the initial ESC guidelines recommended this procedure in patients with a high risk of SAVR. According to ESC guidelines for the treatment of valvular diseases from 2021, the decision on the treatment modality of AS is defined by the Heart team, and SAVR is recommended in younger patients with a low risk of surgery (<75 years STS-PROM/ EuroScore II8%) or in patients not suitable for surgery. In addition, large randomized clinical studies (PARTNER 3, Evolut Low Risk and NOTION studies) showed that TAVI is also safe in patients with a low operative risk (STS-PROM/EuroScore II<4%), and not inferior to SAVR (UK TAVI trial). The first TAVI procedure in Republic of Serbia was performed on April 22, 2014 during BASIC 8+ Congress. In the period of 2014-2023, 444 TAVI procedures were performed in Republic of Serbia, with exponential increase in in the last 2 years.